Open Access

The role of peroxiredoxins in cancer (Review)

  • Authors:
    • Arianna Nicolussi
    • Sonia D'inzeo
    • Carlo Capalbo
    • Giuseppe Giannini
    • Anna Coppa
  • View Affiliations

  • Published online on: January 10, 2017     https://doi.org/10.3892/mco.2017.1129
  • Pages: 139-153
  • Copyright: © Nicolussi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Peroxiredoxins (PRDXs) are a ubiquitously expressed family of small (22‑27 kDa) non‑seleno peroxidases that catalyze the peroxide reduction of H2O2, organic hydroperoxides and peroxynitrite. They are highly involved in the control of various physiological functions, including cell growth, differentiation, apoptosis, embryonic development, lipid metabolism, the immune response, as well as cellular homeostasis. Although the protective role of PRDXs in cardiovascular and neurological diseases is well established, their role in cancer remains controversial. Increasing evidence suggests the involvement of PRDXs in carcinogenesis and in the development of drug resistance. Numerous types of cancer cells, in fact, are characterized by an increase in reactive oxygen species (ROS) production, and often exhibit an altered redox environment compared with normal cells. The present review focuses on the complex association between oxidant balance and cancer, and it provides a brief account of the involvement of PRDXs in tumorigenesis and in the development of chemoresistance.
View Figures
View References

Related Articles

Journal Cover

February-2017
Volume 6 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nicolussi A, D'inzeo S, Capalbo C, Giannini G and Coppa A: The role of peroxiredoxins in cancer (Review). Mol Clin Oncol 6: 139-153, 2017.
APA
Nicolussi, A., D'inzeo, S., Capalbo, C., Giannini, G., & Coppa, A. (2017). The role of peroxiredoxins in cancer (Review). Molecular and Clinical Oncology, 6, 139-153. https://doi.org/10.3892/mco.2017.1129
MLA
Nicolussi, A., D'inzeo, S., Capalbo, C., Giannini, G., Coppa, A."The role of peroxiredoxins in cancer (Review)". Molecular and Clinical Oncology 6.2 (2017): 139-153.
Chicago
Nicolussi, A., D'inzeo, S., Capalbo, C., Giannini, G., Coppa, A."The role of peroxiredoxins in cancer (Review)". Molecular and Clinical Oncology 6, no. 2 (2017): 139-153. https://doi.org/10.3892/mco.2017.1129